The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients

C. Robroeks, M. Roozeboom, P. de Jong, Q. Jöbsis, S. Robben, H. Tiddens, W. Wodzig, J. Damoiseaux, A. Bast, J. B. Yntema, H. Brackel, E. Dompeling (Maastricht, Amersfoort, Rotterdam, Nijmegen, Eindhoven, Veldhoven, Netherlands)

Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session: Cystic fibrosis lung disease: what do we measure? What do we know?
Session type: Electronic Poster Discussion
Number: 348

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Robroeks, M. Roozeboom, P. de Jong, Q. Jöbsis, S. Robben, H. Tiddens, W. Wodzig, J. Damoiseaux, A. Bast, J. B. Yntema, H. Brackel, E. Dompeling (Maastricht, Amersfoort, Rotterdam, Nijmegen, Eindhoven, Veldhoven, Netherlands). The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients. Eur Respir J 2007; 30: Suppl. 51, 348

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009


MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020


Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation
Source: Eur Respir J 2001; 18: Suppl. 33, 537s
Year: 2001

Is NO2/X index useful for evaluation of oxidative stress in exhaled breath condensate in cystic fibrosis?
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

Exhaled pentane – a new breath test in cystic fibrosis?
Source: Annual Congress 2006 - New developments in infant and intensive care lung function
Year: 2006


Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 227s
Year: 2005

Epithelial alarmin levels in exhaled breath condensate in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Inflammatory markers in exhaled breath condensate, assessed by means of Luminex® technology, can differentiate between children with asthma, cystic fibrosis and healthy controls
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010


Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Relationship between acidity of exhaled breath condensate, lung function and airway inflammation in asthmatic children
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


The relationships between markers of inflammation in exhaled breath condensate and bronchoalveolar lavage in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004

Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004

Association of exhaled breath condensate pH with markers of neutrophilic inflammation in bronchoalveolar lavage in young children with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010


Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 468s
Year: 2004

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008